Key result
Early insertion of the Abiomed BVS 5000 allowed 64% of patients to be weaned off support and 43% to be discharged, whereas none of the patients with late postoperative implantation could be weaned.
Why the study?
Does the Abiomed BVS 5000 biventricular support system improve survival and weaning rates in patients requiring circulatory support for severe cardiac surgical conditions?
Population
n=17 patients requiring ventricular support for various cardiac surgical conditions.
Design
Case_series
Authors
Loading...
Early Abiomed BVS 5000 insertion may aid weaning in postcardiotomy shock; leaves open prospective confirmation of benefit.
Observational (n=17)
No
Does the Abiomed BVS 5000 biventricular support system improve survival and weaning rates in patients requiring circulatory support for severe cardiac surgical conditions?
Absolute Event Rate: 64% vs 0%
The Abiomed BVS 5000 can provide life-saving circulatory support in critical cardiac surgical conditions, with more favorable results achieved when the device is placed early.
Samuels et al. (1997) conducted an observational in Cardiac surgical conditions requiring ventricular support (n=17). Abiomed BVS 5000 biventricular support system (early insertion) vs. Postoperative implantation (late insertion) was evaluated on Weaning off support. Early insertion of the Abiomed BVS 5000 allowed 64% of patients to be weaned off support and 43% to be discharged, whereas none of the patients with late postoperative implantation could be weaned.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: